Results 261 to 270 of about 11,127 (277)

Mepolizumab for treatment of adolescents and adults with eosinophilic oesophagitis: a multicentre, randomised, double-blind, placebo-controlled clinical trial

Gut, 2023
Evan S Dellon, Ikuo Hirano
exaly  

Bronchial thermoplasty versus mepolizumab: Comparison of outcomes in a severe asthma clinic

Respirology, 2020
David Langton, Joy Sha, Wei Wang
exaly  

REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study

Drugs, 2021
Christian Domingo, Ebymar Arismendi
exaly  

Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines ‐ recommendations on the use of biologicals in severe asthma

Allergy: European Journal of Allergy and Clinical Immunology, 2020
Ioana Agache, Cezmi A Akdis, Mübeccel Akdis   +2 more
exaly  

Anti‐IL‐5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis

Allergy: European Journal of Allergy and Clinical Immunology, 2005
Dirkjan Hijnen, Edward F Knol
exaly  

Severe eosinophilic asthma and mepolizumab

The Lancet Respiratory Medicine, 2016
openaire   +3 more sources

Real‐world experience with mepolizumab: Does it deliver what it has promised?

Clinical and Experimental Allergy, 2020
Sophie Graff, Florence Schleich, Catherine Moermans   +2 more
exaly  

Mepolizumab effectiveness and identification of super-responders in severe asthma

European Respiratory Journal, 2020
David Langton, Constance H Katelaris, Claude S Farah   +2 more
exaly  

Subcutaneous mepolizumab in children aged 6 to 11 years with severe eosinophilic asthma

Pediatric Pulmonology, 2019
Jonathan Steinfeld, Robert G Price, Atul Gupta   +2 more
exaly  

Real-world mepolizumab in the prospective severe asthma REALITI-A study: initial analysis

European Respiratory Journal, 2020
Tim Harrison, Giorgio Walter Canonica, Geoffrey Chupp   +2 more
exaly